Relmada Therapeutics bolsters Sepranolone Program with Michael Quirk as Senior Advisor
Dr. Quirk said the program’s mechanism offers a targeted approach to disrupted brain signaling in compulsivity-related disorders
Dr. Quirk said the program’s mechanism offers a targeted approach to disrupted brain signaling in compulsivity-related disorders
Developed by the Sudha Gopalakrishnan Brain Centre, the publicly accessible ANCHOR atlas maps over 200 brainstem structures at cellular resolution, offering new possibilities for neuroscience research and clinical applications
If cleared, MAVIRET would become one of the few therapies in the European Union approved to treat both acute and chronic hepatitis C infections
BMS is moving beyond conversational AI into what it describes as “agentic” systems
At the institute's 42nd convocation ceremony, Union Minister described its eight-institution MoU initiative as a unique collaborative effort that brings together premier national institutions to create a synergistic research ecosystem
The test is designed to help clinicians either rule in or rule out amyloid pathology in patients showing signs of cognitive decline
The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics
With the convergence of AI, robotics, and neuroscience, Motorica is advancing toward more intuitive, intent-driven prosthetic systems
The agreement could rise to $900 million if key commercial milestones are met
The centre will leverage AI-enabled tools to support research and diagnostics for complex eye–brain disorders
Subscribe To Our Newsletter & Stay Updated